Domestic pharma sector posts 12 per cent growth in february 2016
Brand India Pharma | March 14, 2016
he pharmaceutical market research company AIOCD AWACS stated that volumes, prices and new launches contributed 3.7 per cent, 5.4 per cent and 3 per cent respectively to domestic market growth. The NLEM (National List of Essential Medicines) portfolio registered a growth of 6.9 per cent y-o-y, while the non-NLEM portfolio grew at 12.9 per cent.